MARY BROOKS: Open Payments
NPI 1336487404 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 75 payments from 16 companies in 2025. Trend: 2023 $320 · 2024 $712 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $366 |
| Hollister Incorporated | 6 | $164 |
| Janssen Biotech, Inc. | 8 | $146 |
| Aimmune Therapeutics, Inc. | 7 | $111 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $101 |
| Gilead Sciences, Inc. | 3 | $73 |
| Madrigal Pharmaceuticals | 2 | $61 |
| Ardelyx, Inc. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $46 |
Products named: RINVOQ, New Image, TREMFYA, ZENPEP, ENTYVIO, CREON, XIFAXAN, REZDIFFRA.
Industry payments across VA — which companies pay providers there.
